PAKOLA STEVE Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$788,501.35

Insider Activity of PAKOLA STEVE

According to the SEC Form 4 filings, PAKOLA STEVE, being in a position of

  1. Chief Medical Officer at REGENXBIO Inc.,
    оver the last 12 months, has bought 0 shares, and sold 78927 shares for $939,970,
    over all time since 2022-01-03, has bought 0 shares, and sold 113778 shares for $1.73M.

Biography of PAKOLA STEVE

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $000
Sells
 $939,9705100

Comparison of Insiders on Amount of Buys and Sells

2026-07-02SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
2,161
0.0043%
$13.64$29,476-32.79%
2026-07-01SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
36,725
0.0763%
$12.86$472,284-31.7%
2026-06-29SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
19,608
0.0354%
$11.04$216,472-22.23%
2026-05-11SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
15,309
0.0324%
$11.02$168,705-18.8%
2026-03-10SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
5,124
0.0101%
$10.35$53,033-12.22%
2024-03-05SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
12,878
0.0328%
$28.36$365,220-52.78%
2024-01-03SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
17,237
0.0398%
$17.39$299,789-26.5%
2023-01-03SaleREGENXBIO Inc.
RGNX
Chief Medical Officer
3,138
0.0072%
$22.17$69,559-14.07%
2022-01-03SaleREGENXBIO Inc.
RGNX
1,598
0.0037%
$33.75$53,933-24.66%
Total: 9
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.